High-flow nasal cannula oxygen therapy for admitted COPD-patients. A retrospective cohort study.

ABSTRACT:

Background

The use of High-flow nasal cannula (HFNC) is increasing in admitted COPD-patients and could provide a step in between non-invasive ventilation (NIV) and standard oxygen supply. Recent studies demonstrated that HFNC is capable of facilitating secretion removal and reduce the work of breathing. Therefore, it might be of advantage in the treatment of acute exacerbations of COPD (AECOPD). No randomized trials have assessed this for admitted COPD-patients on a regular ward and only limited data from non-randomized studies is available.

Objectives

The aim of our study was to identify the reasons to initiate treatment with HFNC in a group of COPD-patients during an exacerbation, further identify those most likely to benefit from HFNC treatment and to find factors associa

SUBMITTER: Veenstra P 

PROVIDER: S-EPMC9534431 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature